Table 5.
Pre- and posttreatment superimposition measurements in both cleft and noncleft group
| Superimposition measurements | Pretreatment -T1 | Posttreatment–T2 | ||||
|---|---|---|---|---|---|---|
| Cleft | Noncleft | Significance | Cleft | Noncleft | Significance | |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
| A-OLp | 76.92 ± 2.43 | 81.53 ± 2.30 | *** | 80.77 ± 2.15 | 83.30 ± 2.52 | ** |
| Pog-OLp | 80.25 ± 1.66 | 85.25 ± 4.00 | *** | 76.69 ± 2.04 | 83.70 ± 4.07 | *** |
| UM-OLp | 51.94 ± 2.36 | 52.75 ± 2.23 | NS | 55.41 ± 2.49 | 55.72 ± 2.16 | NS |
| LM-OLp | 57.03 ± 3.56 | 57.23 ± 2.83 | NS | 57.86 ± 3.51 | 58.12 ± 3.00 | NS |
| U1-OLp | 75.69 ± 2.77 | 79.35 ± 2.67 | *** | 78.94 ± 2.60 | 82.37 ± 3.28 | *** |
| L1-OLp | 80.42 ± 1.91 | 87.53 ± 2.97 | *** | 77.91 ± 2.15 | 85.10 ± 2.84 | *** |
| UM-SN | 70.28 ± 2.62 | 71.85 ± 2.00 | * | 73.00 ± 2.90 | 72.95 ± 1.82 | NS |
| LM-SN | 71.00 ± 2.68 | 75.70 ± 2.56 | *** | 71.88 ± 2.87 | 76.65 ± 2.73 | *** |
NS, not significant; SD, standard deviation; *significant at 5% level (p < 0.05); **significant at 1% level (p < 0.01); ***significant at 0.1% level (p < 0.001)